{"address1": "3-5-1, Nihonbashi-honcho", "address2": "Chuo-ku", "city": "Tokyo", "zip": "103-8426", "country": "Japan", "phone": "81 3 6225 1111", "website": "https://www.daiichisankyo.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia. It also provides olmesartan medoxomil antihypertensive agents; NILEMDO, an oral treatment to help in lowering cholesterol; and Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe for reducing cholesterol. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgalty for the treatment of migraine attacks; Pralia for the treatment of anti-osteoporosis/inhibitor of the progression of bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications caused by bone metastasis from tumors; Tarlige for treating pain; Tenelia for the treatment of Type 2 diabetes mellitus; Venofer for the treatment of iron deficiency anemia; and Vimpat, an anti-epileptic agent. Further, it provides vaccines for influenza, measles/rubella infection, and mumps. The company has a development and commercialization agreement with Merck to jointly develop and commercialize Daiichi Sankyo's DXd antibody drug conjugate (ADC) candidates The company was founded in 1899 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 17435, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sunao  Manabe D.V.M., Ph.D.", "age": 69, "title": "Group CEO & Executive Chairperson", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 280000000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Hiroyuki  Okuzawa", "age": 61, "title": "President, COO & Representative Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 110000000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Masahiko  Ohtsuki", "age": 64, "title": "Senior Managing Exec. Officer, Head of Global DX, Chief Digital Transformation Officer & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 110000000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shoji  Hirashima", "age": 62, "title": "Senior Managing Executive Officer, Head of Japan Business Unit & Representative Director", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 119000000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Koji  Ogawa", "title": "Managing Executive Officer, Head of Global Corporate Planning & Management and CFO", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Hiroto  Kashiwase", "title": "Managing Executive Officer, Head of Technology Management HQ and Head of Supply Chain HQ", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Naoto  Tsukaguchi", "title": "Gen. Counsel, Corp. Officer, Head of Global Leg., IP, Global Compl. and Risk & VP of Leg. Aff. Dept.", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Kentaro  Asakura", "title": "Vice President of Corporate Communications Department", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Marielle  Cohard-Radice M.D.", "title": "Global Head of Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Akio  Sakurai", "title": "Corporate Officer, Head of Sales and Marketing Div. & Japan Business Unit", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 1, "boardRisk": 1, "compensationRisk": 1, "shareHolderRightsRisk": 2, "overallRisk": 1, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 4913.0, "open": 4861.0, "dayLow": 4852.0, "dayHigh": 4932.0, "regularMarketPreviousClose": 4913.0, "regularMarketOpen": 4861.0, "regularMarketDayLow": 4852.0, "regularMarketDayHigh": 4932.0, "dividendRate": 60.0, "dividendYield": 0.012200001, "exDividendDate": 1711584000, "payoutRatio": 0.3609, "fiveYearAvgDividendYield": 1.07, "beta": 0.298, "trailingPE": 50.573406, "forwardPE": 50.313496, "volume": 536100, "regularMarketVolume": 536100, "averageVolume": 4398514, "averageVolume10days": 4499500, "averageDailyVolume10Day": 4499500, "bid": 4895.0, "ask": 4896.0, "marketCap": 9385379102720, "fiftyTwoWeekLow": 3566.0, "fiftyTwoWeekHigh": 5173.0, "priceToSalesTrailing12Months": 6.2424746, "fiftyDayAverage": 4651.86, "twoHundredDayAverage": 4271.1, "trailingAnnualDividendRate": 35.0, "trailingAnnualDividendYield": 0.007123957, "currency": "JPY", "enterpriseValue": 8322009792512, "profitMargins": 0.12375, "floatShares": 1891700807, "sharesOutstanding": 1917340032, "heldPercentInsiders": 0.014450001, "heldPercentInstitutions": 0.53356, "impliedSharesOutstanding": 1936169984, "bookValue": 827.316, "priceToBook": 5.9167237, "lastFiscalYearEnd": 1680220800, "nextFiscalYearEnd": 1711843200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 1.344, "netIncomeToCommon": 186052001792, "trailingEps": 96.79, "forwardEps": 97.29, "pegRatio": 2.22, "lastSplitFactor": "3:1", "lastSplitDate": 1601337600, "enterpriseToRevenue": 5.535, "enterpriseToEbitda": 35.475, "52WeekChange": 0.054812312, "SandP52WeekChange": 0.32311738, "lastDividendValue": 30.0, "lastDividendDate": 1711584000, "exchange": "JPX", "quoteType": "EQUITY", "symbol": "4568.T", "underlyingSymbol": "4568.T", "shortName": "DAIICHI SANKYO COMPANY LIMITED", "longName": "Daiichi Sankyo Company, Limited", "firstTradeDateEpochUtc": 946944000, "timeZoneFullName": "Asia/Tokyo", "timeZoneShortName": "JST", "uuid": "bcc3658f-95bb-3d6b-b9ac-cf76ff389d04", "messageBoardId": "finmb_23697721", "gmtOffSetMilliseconds": 32400000, "currentPrice": 4895.0, "targetHighPrice": 6200.0, "targetLowPrice": 4200.0, "targetMeanPrice": 5607.7, "targetMedianPrice": 5800.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 1201011032064, "totalCashPerShare": 626.358, "ebitda": 234584997888, "totalDebt": 101805998080, "quickRatio": 2.792, "currentRatio": 3.563, "totalRevenue": 1503470944256, "debtToEquity": 6.415, "revenuePerShare": 784.136, "returnOnAssets": 0.03735, "returnOnEquity": 0.12433, "freeCashflow": -22623750144, "operatingCashflow": 601668976640, "earningsGrowth": 1.344, "revenueGrowth": 0.313, "grossMargins": 0.72281, "ebitdaMargins": 0.15603, "operatingMargins": 0.22261, "financialCurrency": "JPY", "trailingPegRatio": 1.5495}